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Abstract Purpose: Bronchoscopy
is an indispensable tool for invasive
pulmonary evaluation with high
diagnostic yield and low incidence of
major complications. However, hyp-
oxemia increases the risk of
complications, in particular after
bronchoalveolar lavage. Non-invasive
positive pressure ventilation may
prevent hypoxemia associated with
bronchoalveolar lavage. The purpose
of this study is to present a modiﬁed
total face mask to aid bronchoscopy
during non-invasive positive pressure
ventilation. Methods: A commer-
cially available full face mask was
modiﬁed to allow introduction of the
bronchoscope without interfering
with the ventilator circuit. Broncho-
scopy with bronchoalveolar lavage
was performed in 12 hypoxemic non-
ICU patients during non-invasive
positive pressure ventilation in the
ICU. Results: Patients had severely
impaired oxygen uptake as indicated
by PaO2/FiO2 ratio 192 ± 23 mmHg
before bronchoscopy. Oxygenation
improved after initiation of non-
invasive positive pressure ventilation.
In all patients the procedure could be
completed without subsequent com-
plications, although in one patient
SpO2 decreased until 86% during
bronchoscopy. A microbiological
diagnosis could be established in 8 of
12 patients with suspected for infec-
tion. Conclusions: Our modiﬁed
face mask for non-invasive positive
pressure ventilation is a valuable tool
to aid diagnostic bronchoscopy in
hypoxemic patients.
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Introduction
Flexible bronchoscopy is used for diagnostic or thera-
peutic purposes of the airways or lung tissue. In general,
bronchoscopy is a safe intervention with reported serious
complications of 0.08% and mortality of 0.01% [1].
Hypoxemia during or after bronchoscopy may occur as
the result of ventilation/perfusion mismatch. Reduction in
arterial oxygen pressure (PaO2) during bronchoscopy is
*7.7 mmHg [2], but after bronchoalveolar lavage PaO2
may decrease by 23 mmHg [3]. Ventilation/perfusion
mismatch may persist 15–24 h [4, 5]. Such reduction in
PaO2 does not carry signiﬁcant risks for patients without
pre-existent hypoxemia or cardiac disease and can be
corrected by nasal oxygen supplementation. However, in
patients with hypoxemia before bronchoscopy, further
reduction in PaO2 may increase the risk of acute respi-
ratory failure, cardiac ischemia and arrhythmias [6].
Therefore, clinicians may be reluctant to perform diag-
nostic bronchoscopy in hypoxemic patients, in spite of the
high diagnostic yield, even in critically ill patients [7].
Few studies have investigated the role of non-invasive
positive pressure ventilation (NPPV) to prevent hypo-
xemia during bronchoscopy. Antonelli et al. [8] assessed
the feasibility and safety of a full face mask to aid
bronchoscopy during non-invasive ventilation. Maitre
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pressure (CPAP) during bronchoscopy in hypoxemic
patients prevents oxygen desaturation and acute respira-
tory failure. However, in this latter study a speciﬁc CPAP
device was needed, and it does not allow pressure support
ventilation. We present a new NPPV face mask to aid
bronchoscopy in hypoxemic patients.
Materials and methods
Modiﬁed face mask
A commercially available full face mask (Repironics
)
was modiﬁed by the authors to allow introduction of the
bronchoscope without interfering with the ventilator cir-
cuit. Accordingly, a plastic cylinder was secured in the
mask at a position that allows introduction of broncho-
scope through the mouth (Figs. 1, 2). A disposable cap
(from a swivel connector) was used to seal the cylinder
and prevent air leakage during bronchoscopy.
Study population
The use of non-invasive mechanical ventilation during
bronchoscopy in hypoxemic patients is the standard
clinical practice in our hospital. Routine monitoring
includes invasive blood pressure, peripheral oxygen sat-
uration and heart rhythm. No additional measurements
were performed for the current study. Therefore, formal
approval for the current study was waived.
To demonstrate the feasibility of the modiﬁed face
mask during diagnostic bronchoscopy 12 patients were
prospectively analyzed. Non-ICU patients with indica-
tions for bronchoscopy and bronchoalveolar lavage, but
reluctance of an experienced pulmonologist to perform
this procedure because of hypoxemia or severe respiratory
distress were included. Exclusion criteria are the recog-
nized contraindications for NPPV, such as reduced level
of consciousness, recent facial or esophageal surgery, and
inability to tolerate the face mask.
Bronchoscopy
Patients were admitted to the ICU solely for the purpose of
bronchoscopy. Patients refrained from oral intake, except
water, for 6 h prior to the intervention. An arterial catheter
was inserted into the radial artery for blood withdrawal
and hemodynamic monitoring. All patients had venous
access before ICU admission. Pulse-oximetry and heart
rhythm (5-lead ECG) were continuously monitored.
Twenty minutes before bronchoscopy, patients were
connected to NPPV to allow acclimatization. Positive end
expiratory pressure (PEEP) was set at 6 cmH2O, pressure
support 10 cmH2O and FiO2 1.0. Topical anesthesia of the
mouth and pharynx was achieved with xylocaine spray
(10%). To this end the mask was brieﬂy removed from the
face. Additional xylocaine (1%) was administered through
the bronchoscope as needed for topical aneasthesia of the
vocal cords and trachea. The bronchoscope (Videoscope,
Olympus
, diameter 4.9, 6.0 or 6.3 mm) was introduced
Fig. 1 Full face mask modiﬁed for the use of bronchoscopy during
non-invasive positive pressure ventilation. A synthetic cylinder was
secured in the mask. A disposable cap sealed the cylinder and
prevented air leakage during bronchoscopy
Fig. 2 Oral introduction of the ﬂexible bronchoscope through the
modiﬁed face mask during NPPV. Written permission for publi-
cation by patient
144via the plastic cylinder in the face mask (Fig. 2). Bron-
choscopy and bronchoalveolar lavage were performed
according to clinical protocols. After bronchoscopy, pres-
sure support and FiO2 were tapered while maintaining
oxygensaturationabove92%.WhenFiO2wasdecreasedto
*0.4, while patients maintained arterial oxygen saturation
above 92% without respiratory distress, NPPV was dis-
continued. Oxygen was then supplemented through a non-
rebreathingmask.PatientsremainedintheICUfor12–24 h
with continuously monitoring of SpO2 and heart rhythm.
Arterial blood gasses were withdrawn before starting
NPPV, during NPPV before and after bronchoscopy, and
after discontinuing NPPV.
Results
Patient characteristics
Patient characteristics are shown in Table 1. Suspected
infection was the most common reason for bronchoscopy.
Only in patients 1 and 9 was bronchoscopy performed
because of suspected interstitial lung disease. Except for
patients 1, 9, 11 and 12, patients were immunocompro-
mised at the time of bronchoscopy, either due to
medication or recent stem cell transplantation. In one
patient a low dose (50 mg/h) of propofol and in two
patients a low dose of midazolam (2.5–7.0 mg) were
administered during bronchoscopy because of agitation.
As shown in Table 1, all patients had severely
impaired oxygen uptake before bronchoscopy at the
general ward. The PaO2/FiO2 ratio before NPPV, during
NPPV but before bronchoscopy and 1 h after broncho-
scopy is shown in Fig. 3.
Complications and outcome
On average, patients were on NPPV for 6 h (range 2–
24 h). All but two patients were transferred to the general
ward within 24 h after ICU bronchoscopy.
In one patient SpO2 decreased to 86% during bron-
choscopy (Table 1). In this patient, the bronchoscope was
brieﬂy withdrawn to allow re-oxygenation. The procedure
could be completed without subsequent complications.
None of our patients showed arrhythmias or ST segment
Table 1 Patient characteristics at baseline, oxygenation, time spent on ventilator and amount of lavage ﬂuid injected and retrieved
No. Sex/age
(years)
Relevant medical history PaO2 before
NPPV
(mmHg)/ O2
(l/min)
Lowest
SpO2
(%)
Time on
NPPV
(h)
Lavage ﬂuid
in/out (ml)
1 F/69 Myocardial infarction, renal failure 76/5 94 4 80/25
2 F/62 Non-Hodgkin lymphoma, pulmonary embolism, 52/5 100 4 120/60
3 M/57 Polymyositis, CABG (59) 62/5 99 7 180/40
4 M/58 Aspiration pneumonia, secondary hyperparathyroidism,
alcoholic gastritis
83/4 99 4 180/110
5 F/48 Multiple myeloma, allogeneic stem cell transplant, GvHD 51/0 100 2 60/20
6 M/75 Non-Hodgkin lymphoma, prostatic carcinoma, CVA,
spondylodiscitis
65/3 86 5 180/50
7 F/54 Still disease, COPD 65/5 100 4 150/50
8 F/62 Lymphoma, autologous stem cell transplantation, 76/4 96 3 180/50
9 F/73 Coloncarcinoma T3N2Mx, polymyalgia rheumatic,
angina pectoris
85/2 96 6 180/40
10 M/76 Kidney transplant, pulmonary embolism, sec. osteoporosis 100/3 100 4 200/50
11 M/54 Cerebral abscess, endocarditis, DM2 56/5 100 6 220/20
12 M/83 Renal insufﬁciency, COPD 49/5 94 24 100/30
F Female, M male, CABG coronary artery bypass graft, CVA cerebral vascular accident, COPD chronic obstructive pulmonary disease,
DM2 diabetes mellitus type 2
Fig. 3 PaO2/FiO2 ratio before initiation of NPPV, after 15 min of
NPPV and after diagnostic bronchoscopy but during NPPV.
*P\0.001 versus before NPPV and versus during NPPV, after
bronchosocpy
145elevation/depression on ﬁve-lead ECG during or after the
intervention.
Patient 2 could initially be weaned from NPPV within
2 h after bronchoscopy, and was well saturated with5 l/min
nasal O2 for several hours. However, his clinical condition
deteriorated, requiring reinstitution of non-invasive venti-
lationand28 hafterbronchoscopy,endotrachealintubation.
Culture of the lavage in this patient revealed Pneumocystis
jiroveci.
In eight of the patients a causative infectious agent
was found, including Pneumocystis jiroveci, Streptococ-
cus milleri, Streptococcus mitis, Rhinovirus and
Enterobacter aerogenes.
Discussion
Hypoxemia is a well-known contraindication for bron-
choscopy [6] due to the risk of acute respiratory failure,
cardiac ischemia and arrhythmias during or after the
intervention. Accordingly, in hypoxemic patients, physi-
cians may either decline bronchoscopy or choose to
intubate these patients to facilitate bronchoscopy. The
current study shows that our modiﬁed face mask for
NPPV is a feasible alternative for endotracheal intubation
to facilitate bronchoscopy in a selection of these patients.
The feasibility of non-invasive ventilation to aid
bronchoscopy has been published previously [8, 9]. These
studies showed that non-invasive ventilation maintains
oxygenation during bronchoscopy. Moreover, the study
by Maitre et al. [9] suggests that CPAP prevents acute
respiratory failure, as indicated by fewer patients requir-
ing endotracheal intubation within 6 h after procedure.
However, the device to generate positive pressure used by
Maitre and colleagues [9] is not easily available and only
allows CPAP. Our mask has several advantages compared
to the devices used in the previous two studies on
non-invasive ventilation during bronchoscopy [8, 9], such
as the ability to deliver pressure support ventilation [9],
which seems reasonable during bronchoscopy to reduce
the work of breathing. In addition, the increased distance
between the mask and face of the patient allows better
positioning of the bronchoscope, and the bronchoscope is
not directly inserted into the ventilatory circuit. Finally,
no speciﬁc equipment is required, and both nurses and
intensive care staff are familiar with both the mask and
ventilator used. Therefore, no special training is needed.
In our experience this mask can be used in all patients in
whom hypoxemia could be reversed with non-invasive
positivepressureventilation.Indeed,wehaveusedthismask
to perform bronchoscopy with bronchoalveolar lavage in
patients with PaO2 as low as 51 mmHg (without supple-
mentaloxygen).Inaddition,theauthorshaveusedthismask
to facilitate transbronchial biopsy in hypoxemic patients.
Nevertheless,severalprecautionsshouldbeconsidered.
First, in these high-risk patients bronchoscopy should be
performedbyanexperiencedphysicianandinthepresence
of staff trained in emergency endotracheal intubation.
Second,occasionallyprolongednon-invasiveventilationis
needed after bronchoscopy in these patients. Because of
induction of shunt and possible inﬂammatory response due
tolavage solution[10–12],approximately24 hmonitoring
is recommended [4, 5]. Third, general contra-indications
fornon-invasiveventilation,includingsevereagitationand
reduced level of consciousness, apply to our mask as well.
Thesafetyofthismaskhasnotbeenformallytestedina
randomized trial, nor has the clinical outcome been asses-
sed. To demonstrate the safety of our mask, hypoxemic
patients with need for diagnostic bronchoscopy should be
randomized to either bronchoscopy during non-invasive
ventilation or after endotracheal intubation. As the authors
have used this mask in over 75 patients without adverse
events, it was felt unethical to perform such study. In
addition,thevalueofbronchoalveolarlavageinobtaininga
microbiological diagnosis, especially in immunocompro-
mised patients, has been shown previously [13].
In conclusion, the current paper presents a modiﬁed
mask to facilitate diagnostic bronchoscopy during NPPV
in hypoxemic patients.
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